PRKN and neoplasm: To investigate the tumor suppressor effect of PARK2 in vivo, we retro-orbitally injected luciferase-labeled H1299 cells overexpressing EV or human PARK2. Ectopic expression of PARK2 significantly mitigated the formation of lung metastases (Figures 3F–3I) in NOD/SCID mice.